Reese Tim, Pagel Gregor, Bause Bettina A, von Rittberg York, Wagner Kim C, Oldhafer Karl J
Asklepios Campus Hamburg, Semmelweis University of Medicine, 20099 Hamburg, Germany.
Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Asklepios Hospital Barmbek, Rübenkamp 220, 22291 Hamburg, Germany.
J Clin Med. 2021 Apr 13;10(8):1672. doi: 10.3390/jcm10081672.
The only curative treatment option for intrahepatic cholangiocarcinoma (iCCA) is liver resection. Due to central tumor localization and vascular invasion, complex liver resections play an important role in curative treatment. However, the long-term outcomes after complex liver resection are not known. A retrospective cohort study was conducted for all patients undergoing liver surgery for iCCA. Complex liver resections included ante situm resections, associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and major liver resection with vascular reconstructions. Forty-nine patients (34%) received complex liver resection, 66 patients (46%) received conventional liver resection and 28 patients (20%) were not resectable during exploration. Preoperative characteristics were not different between the groups, except for Union for International Cancer Control (UICC) stages. The postoperative course for complex liver resections was associated with more complications and perioperative mortality. However, long-term survival was not different between complex and conventional resections. Independent risk factors for survival were R0 resections and UICC stage. Four patients underwent ante situm resection without any mortality. Complex liver resections are justified in selected patients and survival is comparable with conventional liver resections. Survival in iCCA is affected by UICC stage or resections margins and not by the complexity of the case.
肝内胆管癌(iCCA)唯一的治愈性治疗选择是肝切除术。由于肿瘤位于中央且存在血管侵犯,复杂肝切除术在治愈性治疗中发挥着重要作用。然而,复杂肝切除术后的长期疗效尚不清楚。对所有接受iCCA肝手术的患者进行了一项回顾性队列研究。复杂肝切除术包括原位切除术、联合肝脏分隔和门静脉结扎分期肝切除术(ALPPS)以及伴有血管重建的大范围肝切除术。49例患者(34%)接受了复杂肝切除术,66例患者(46%)接受了传统肝切除术,28例患者(20%)在探查时无法切除。除国际癌症控制联盟(UICC)分期外,各组术前特征无差异。复杂肝切除术的术后病程与更多并发症和围手术期死亡率相关。然而,复杂肝切除术和传统肝切除术的长期生存率并无差异。生存的独立危险因素是R0切除和UICC分期。4例患者接受原位切除术,无任何死亡。在特定患者中,复杂肝切除术是合理的,其生存率与传统肝切除术相当。iCCA的生存受UICC分期或手术切缘影响,而非病例的复杂性。